Boston Partners - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 268 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 3.49 and the average weighting 0.1%.

Quarter-by-quarter ownership
Boston Partners ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,328,666
+57.2%
108,509
+105.4%
0.01%
+66.7%
Q2 2023$2,116,845
-33.3%
52,830
-32.0%
0.00%
-25.0%
Q1 2023$3,171,350
+5.9%
77,710
+0.2%
0.00%0.0%
Q4 2022$2,994,360
-44.0%
77,554
-22.9%
0.00%
-50.0%
Q3 2022$5,350,000
+107.1%
100,589
+127.0%
0.01%
+100.0%
Q2 2022$2,583,000
-23.0%
44,307
+0.8%
0.00%0.0%
Q1 2022$3,354,000
+380.5%
43,945
+279.0%
0.00%
+300.0%
Q4 2021$698,00011,5940.00%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Key Colony Management, LLC 134,600$13,045,00011.31%
Biondo Investment Advisors, LLC 279,717$27,110,0008.33%
GILDER GAGNON HOWE & CO LLC 3,177,130$307,927,0004.48%
DARUMA CAPITAL MANAGEMENT LLC 814,470$78,938,0003.47%
MAGEE THOMSON INVESTMENT PARTNERS LLC 126,022$12,214,0003.01%
NEXT CENTURY GROWTH INVESTORS LLC 768,396$74,472,0002.63%
MARXE AUSTIN W & GREENHOUSE DAVID M 180,000$17,446,0002.38%
Lisanti Capital Growth, LLC 48,280$4,679,0002.35%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 79,017$7,658,0002.00%
Atika Capital Management LLC 21,500$2,084,0001.60%
View complete list of PACIRA PHARMACEUTICALS INC shareholders